Cue Biopharma (CUE) Insider Trading & Ownership $0.86 +0.11 (+14.04%) Closing price 10/8/2025 04:00 PM EasternExtended Trading$0.87 +0.01 (+1.28%) As of 04:15 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Cue Biopharma (NASDAQ:CUE) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage10.78%Number OfInsiders Buying(Last 12 Months)1Amount OfInsider Buying(Last 12 Months)$30.90KNumber OfInsiders Selling(Last 12 Months)0 Get CUE Insider Trade Alerts Want to know when executives and insiders are buying or selling Cue Biopharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. CUE Insider Buying and Selling by Quarter Cue Biopharma Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails12/16/2024Daniel R PasseriCEOBuy30,000$1.03$30,900.00 (Data available from 1/1/2013 forward) CUE Insider Trading Activity - Frequently Asked Questions Who is on Cue Biopharma's Insider Roster? The list of insiders at Cue Biopharma includes Anish Suri, Daniel R Passeri, and Peter A Kiener. Learn more on insiders at CUE. What percentage of Cue Biopharma stock is owned by insiders? 10.78% of Cue Biopharma stock is owned by insiders. Learn more on CUE's insider holdings. Which Cue Biopharma insiders have been buying company stock? The following insider purchased CUE shares in the last 24 months: Daniel R Passeri ($30,900.00). How much insider buying is happening at Cue Biopharma? Insiders have purchased a total of 30,000 CUE shares in the last 24 months for a total of $30,900.00 bought. Cue Biopharma Key ExecutivesMr. Daniel R. Passeri J.D. (Age 63)M.Sc., CEO & Director Compensation: $607.98kDr. Anish Suri Ph.D. (Age 50)President & Chief Scientific Officer Compensation: $447.34kMs. Kerri-Ann Millar (Age 54)Chief Financial Officer Compensation: $447.34kDr. Ronald D. Seidel III (Age 48)Ph.D., Co-Founder Compensation: $316.63kMr. Colin G. Sandercock J.D. (Age 67)MSE, Senior VP, General Counsel & Secretary Compensation: $381.42kDr. Matteo Levisetti M.D. (Age 55)Chief Medical Officer More Insider Trading Tools from MarketBeat Related Companies Cabaletta Bio Insider Selling Black Diamond Therapeutics Insider Selling Enanta Pharmaceuticals Insider Selling Caribou Biosciences Insider Selling Tonix Pharmaceuticals Insider Selling Neoleukin Therapeutics Insider Selling Protalix BioTherapeutics Insider Selling Aclaris Therapeutics Insider Selling SELLAS Life Sciences Group Insider Selling Journey Medical Insider Selling Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Marvell Insiders Buy Shares—Should Investors Follow Suit?This Insider Just Made a Massive Bet on Transocean's ComebackInsider Sales Jump at Broadcom and CoreWeave: Red Flag Ahead?Oklo Insiders Sell! Oh No! This Is Why Investors Shouldn’t WorryTop Insider Buys and Sells From September: Buy, Sell, or Hold? This page (NASDAQ:CUE) was last updated on 10/9/2025 by MarketBeat.com Staff From Our PartnersBitcoin grabs headlines, but smart money likes this tokenBitcoin grabs headlines, but smart money likes this token My research team has identified the token positio...Crypto 101 Media | SponsoredMagnificent 7 being replaced by the “Hidden 7”?BULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | SponsoredREVEALED: Something Big Happening Behind White House DoorsWhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | Sponsored$3,600 gold is nice ... but here’s what most gold bugs are missingGold just surged past $3,600, but Weiss Ratings expert Sean Brodrick says the real upside is in select gold st...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cue Biopharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cue Biopharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
